ArticleMolecular diversity2026
Heterogeneous dual-channel and interpretable graph representation learning with global virtual nodes for microRNA-mediated drug sensitivity prediction.
Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Drug sensitivity critically affects therapeutic outcomes, and microRNAs (miRNAs) play a key role in regulating drug response by modulating genes involved in drug metabolism and action. However, existing computational methods for predicting miRNA-drug sensitivity associations are often limited by heterogeneous network structures and severe data sparsity, which hinder effective feature propagation and robust learning. To address these challenges, we propose HDIGRL, a channel-aware heterogeneous graph representation learning framework centered on channel-gated global heterogeneous propagation for miRNA-mediated drug sensitivity prediction. HDIGRL models miRNAs and drugs from complementary structural and interaction-derived perspectives via a dual-channel feature extraction strategy. HDIGRL introduces channel-gated global heterogeneous propagation, in which global virtual nodes first enable graph-level context exchange and a channel-wise propagation gate then recalibrates propagated embeddings to emphasize discriminative feature channels and suppress noisy or redundant ones. In addition, an imbalance-aware focal loss is adopted to improve robustness under extreme class imbalance. Experimental results on public datasets demonstrate that HDIGRL consistently outperforms existing methods, and further analyses reveal latent miRNA-mediated drug-sensitivity pathways, highlighting its potential for predictive modeling and biological interpretation.
Indexed as
Identifiers
42423923What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.